RU 58841-Myristate Prodrug Development for Topical Treatment of Acne and Androgenetic Alopecia

    January 2005 in “ PubMed ”
    U. Münster, C Nakamura, A. Haberland … Monika Schäfer-Korting
    Studysummary This study reports that RU 58841-myristate, a new antiandrogen prodrug formulated with solid lipid nanoparticles, shows potential for targeting hair follicles in preclinical laboratory settings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pubmed.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Related research 7

    1. Culture of the Human Pilosebaceous Unit, Hair Follicle, and Sebaceous Gland Experimental Dermatology · 2018
    2. Microenvironmental Reprogramming by Three-Dimensional Culture Enables Dermal Papilla Cells to Induce De Novo Human Hair-Follicle Growth Proceedings of the National Academy of Sciences of the United States of America · 2013
    3. Effect of Intense Pulsed Light Treatment on Human Skin In Vitro: Analysis of Immediate Effects on Dermal Papillae and Hair Follicle Stem Cells British Journal of Dermatology · 2013
    4. Characterization of Hair Follicle Development in Engineered Skin Substitutes PLOS ONE · 2013
    5. RU 58841-Myristate Prodrug Development for Topical Treatment of Acne and Androgenetic Alopecia PubMed · 2005
    6. Localization of Sex Steroid Receptors in Human Skin PubMed · 2004
    7. Hormones and Hair Growth: Variations in Androgen Receptor Content of Dermal Papilla Cells Cultured from Human and Red Deer Hair Follicles ˜The œjournal of investigative dermatology/Journal of investigative dermatology · 1993